Editorial: The role of E2F transcription factors in cancer

Ainhoa Iglesias-Ara; Bart Westendorp

doi:10.3389/fonc.2023.1355610

Editorial: The role of E2F transcription factors in cancer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	1355610
Pages (from-to)	1-2
Number of pages	2
Journal	Frontiers in Oncology
Volume	13
DOIs	https://doi.org/10.3389/fonc.2023.1355610
Publication status	Published - 2023

Keywords

E2F
cancer
biomarker
co-regulators
lung cancer
breast cancer
colon cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2023.1355610Licence: CC BY

fonc-13-1355610Final published version, 243 KBLicence: CC BY

Cite this

@article{d296c08906194463a3476f65af3d96b1,

title = "Editorial: The role of E2F transcription factors in cancer",

keywords = "E2F, cancer, biomarker, co-regulators, lung cancer, breast cancer, colon cancer",

author = "Ainhoa Iglesias-Ara and Bart Westendorp",

year = "2023",

doi = "10.3389/fonc.2023.1355610",

language = "English",

volume = "13",

pages = "1--2",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - The role of E2F transcription factors in cancer

AU - Iglesias-Ara, Ainhoa

AU - Westendorp, Bart

PY - 2023

Y1 - 2023

KW - E2F

KW - cancer

KW - biomarker

KW - co-regulators

KW - lung cancer

KW - breast cancer

KW - colon cancer

U2 - 10.3389/fonc.2023.1355610

DO - 10.3389/fonc.2023.1355610

M3 - Article

C2 - 38239640

SN - 2234-943X

VL - 13

SP - 1

EP - 2

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1355610

ER -